Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
NPJ Syst Biol Appl ; 10(1): 68, 2024 Jun 21.
Article in English | MEDLINE | ID: mdl-38906870

ABSTRACT

Combination therapy is well established as a key intervention strategy for cancer treatment, with the potential to overcome monotherapy resistance and deliver a more durable efficacy. However, given the scale of unexplored potential target space and the resulting combinatorial explosion, identifying efficacious drug combinations is a critical unmet need that is still evolving. In this paper, we demonstrate a network biology-driven, simulation-based solution, the Simulated Cell™. Integration of omics data with a curated signaling network enables the accurate and interpretable prediction of 66,348 combination-cell line pairs obtained from a large-scale combinatorial drug sensitivity screen of 684 combinations across 97 cancer cell lines (BAC = 0.62, AUC = 0.7). We highlight drug combination pairs that interact with DNA Damage Response pathways and are predicted to be synergistic, and deep network insight to identify biomarkers driving combination synergy. We demonstrate that the cancer cell 'avatars' capture the biological complexity of their in vitro counterparts, enabling the identification of pathway-level mechanisms of combination benefit to guide clinical translatability.


Subject(s)
DNA Damage , Neoplasms , Humans , DNA Damage/drug effects , Cell Line, Tumor , Neoplasms/genetics , Neoplasms/drug therapy , Signal Transduction/drug effects , Signal Transduction/genetics , Biomarkers, Tumor/genetics , Drug Discovery/methods , Antineoplastic Agents/pharmacology , Drug Synergism , Systems Biology/methods , Antineoplastic Combined Chemotherapy Protocols/pharmacology , Computer Simulation , Avatar
2.
NPJ Syst Biol Appl ; 8(1): 19, 2022 06 09.
Article in English | MEDLINE | ID: mdl-35680961

ABSTRACT

Regulation of translocating proteins is crucial in defining cellular behaviour. Epithelial-mesenchymal transition (EMT) is important in cellular processes, such as cancer progression. Several orchestrators of EMT, such as key transcription factors, are known to translocate. We show that translocating proteins become enriched in EMT-signalling. To simulate the compartment-specific functions of translocating proteins we created a compartmentalized Boolean network model. This model successfully reproduced known biological traits of EMT and as a novel feature it also captured organelle-specific functions of proteins. Our results predicted that glycogen synthase kinase-3 beta (GSK3B) compartment-specifically alters the fate of EMT, amongst others the activation of nuclear GSK3B halts transforming growth factor beta-1 (TGFB) induced EMT. Moreover, our results recapitulated that the nuclear activation of glioma associated oncogene transcription factors (GLI) is needed to achieve a complete EMT. Compartmentalized network models will be useful to uncover novel control mechanisms of biological processes. Our algorithmic procedures can be automatically rerun on the https://translocaboole.linkgroup.hu website, which provides a framework for similar future studies.


Subject(s)
Epithelial-Mesenchymal Transition , Neoplasms , Epithelial-Mesenchymal Transition/genetics , Humans , Signal Transduction/genetics , Transcription Factors/genetics , Transcription Factors/metabolism
3.
J Phys Chem B ; 125(7): 1716-1726, 2021 02 25.
Article in English | MEDLINE | ID: mdl-33562960

ABSTRACT

Network science is an emerging tool in systems biology and oncology, providing novel, system-level insight into the development of cancer. The aim of this project was to study the signaling networks in the process of oncogenesis to explore the adaptive mechanisms taking part in the cancerous transformation of healthy cells. For this purpose, colon cancer proved to be an excellent candidate as the preliminary phase, and adenoma has a long evolution time. In our work, transcriptomic data have been collected from normal colon, colon adenoma, and colon cancer samples to calculating link (i.e., network edge) weights as approximative proxies for protein abundances, and link weights were included in the Human Cancer Signaling Network. Here we show that the adenoma phase clearly differs from the normal and cancer states in terms of a more scattered link weight distribution and enlarged network diameter. Modular analysis shows the rearrangement of the apoptosis- and the cell-cycle-related modules, whose pathway enrichment analysis supports the relevance of targeted therapy. Our work enriches the system-wide assessment of cancer development, showing specific changes for the adenoma state.


Subject(s)
Adenoma , Carcinoma , Colonic Neoplasms , Adenoma/genetics , Colonic Neoplasms/genetics , Humans , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...